Approval · Notice of Compliance 13156 · 2012
ZOLMITRIPTAN: Notice of Compliance 13156
Issued March 28, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13156
- Date
- March 28, 2012
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- 5-HT1 Receptor Agonist - Migraine Therapy
- Canadian reference product
- ZOMIG, ZOMIG RAPIMELT (Astrazeneca Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOLMITRIPTAN | 02379929 | Cancelled Post Market |
| ZOLMITRIPTAN ODT | 02379988 | Cancelled Post Market |
Medicinal ingredients
- ZOLMITRIPTAN 2.5 MG per TAB